HUA-SHENG CHIU to Hematologic Neoplasms
This is a "connection" page, showing publications HUA-SHENG CHIU has written about Hematologic Neoplasms.
Connection Strength
0.170
-
Early Therapeutic Drug Monitoring Optimizes Teicoplanin Use in Febrile Neutropenic Patients with Hematological Malignancies. Adv Ther. 2024 Jul; 41(7):2966-2977.
Score: 0.170
Connection Strength
The connection strength for concepts is the sum of the scores for each matching publication.
Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.